
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
BioIVT, a provider of research models and services for drug development, announced that it has acquired Clinical Trials Laboratory Services, a donor center and laboratory based in London, UK. With this acquirement, BioIVT hopes to ship high quality blood products and blood-derived immune cells efficiently to researchers throughout Europe.
Read the full release






